Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1672648 | 0.73 | ALDH1A1 (0.43) | — | |
| SCHEMBL6256201 | 0.70 | MAPT (0.44) | MAOB | |
| SCHEMBL8443578 | 0.70 | MAOB (0.46) | MAOB | |
| SCHEMBL3685297 | 0.69 | ADRA2A (0.45) | — | |
| SCHEMBL7808907 | 0.69 | KDM4E (0.42) | — | |
| SCHEMBL2958656 | 0.69 | CA1 (0.36) | — | |
| SCHEMBL5567669 | 0.68 | KDM4E (0.36) | — | |
| SCHEMBL1018789 | 0.68 | ALOX5 (0.46) | MAOB | |
| SCHEMBL7186438 | 0.68 | ATM (0.32) | — | |
| SCHEMBL931606 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6313117-B1 | TREATING AUTOIMMUNE DISORDERS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2001-11-06 | — | — | US | claimed |
| CN-112996800-B | Novel proteolytically targeted chimeras (PROTAC) and derivatives thereof as SMARCA2 and/or SMARCA4 degrading agents | 勃林格殷格翰国际有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-109748901-B | Condensed cyclic compound and organic light-emitting device including the same | 三星显示有限公司 | 2024-04-23 | — | — | CN | disclosed |
| CN-111741954-B | Novel benzimidazole compounds and derivatives as EGFR inhibitors | 勃林格殷格翰国际有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-114007698-B | Macrocyclic compounds and derivatives as EGFR inhibitors | 勃林格殷格翰国际有限公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-111163775-B | Novel [1,6] naphthyridine compounds and derivatives as CDK8/CDK19 inhibitors | 勃林格殷格翰国际有限公司 | 2023-07-11 | — | — | CN | disclosed |
| CN-116234806-A | Cyclic 2-amino-3-cyanothiophenes and derivatives thereof for the treatment of cancer | 勃林格殷格翰国际有限公司 | 2023-06-06 | — | — | CN | disclosed |